米非司酮联合小金胶囊治疗子宫内膜异位症的临床研究

目的:观察米非司酮联合小金胶囊治疗子宫内膜异位症的临床疗效。方法:将本院120例符合子宫内膜异位症诊断标准的患者随机分为2组。对照组60例.给予米非司酮口服治疗。观察组60例,给予米非司酮联合小金胶囊口服。2组患者均连续治疗6个月后,观察2组治疗后的有效率、血清CA125、性激素水平、复发率及不良反应发生率等指标。结果:观察组临床总有效率均高于对照组(P0.05),血清CA125、复发率低于对照组(P0.05);2组性激素水平无明显差异(P0.05)。结论:米非司酮联合小金胶囊对子宫内膜异位症有一定的疗效,值得临床推广。

Clinical Research on Effects of Mifepristone Combined with Xiaojin Capsule in the Treatment of Endometriosis

To observe the clinical effect of mifepristone combined with Xiaojin Capsule in the treatment of endometriosis.Methods:A total of 120 patients diagnosed as uterine fibroids were randomized divided into 2 groups.The control group (60 patients) were treated with Mifepristone, and the treatment group (60 patients) were added Xiaojin capsule.The effective rate, the levels of CA125, the levels of sex hormone, recurrence rate and adverse reaction of two groups after continuous 6 months'' treatment were observed.Results:The total effective rate of treatment group was significantly higher than that of control group (P<0 05), and the levels of CA125 and recurrence rate were lower than that of control group.There was no significant difference in the levels of sex hormone (P>0.05).There were no significant difference in sex hormone levels of two groups (P>0.05).Conclusion:Mifepristone combined with Xiaojin capsule is effective for patients with endometriosis, which is worthy of clinical promotion.